<DOC>
	<DOC>NCT01883024</DOC>
	<brief_summary>The purpose of the study is to assess the relevance of the advices provided by the IPRA© smartphone application for guiding the responses of insulin pump treated type 1 diabetes patients using real-time continuous glucose monitoring.</brief_summary>
	<brief_title>Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.</brief_title>
	<detailed_description>Patients will be asked to evaluate the IPRA advices by connecting to IPRA© application by using their smartphone, 30 times a week for two weeks. At the end of this two week period, a satisfaction questionnaire will be completed.</detailed_description>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>men and women ≥ 18 years of age, patients with type 1 diabetes for more than 2 years, patients treated by insulin pump for more than 6 months, patients using of realtime continuous glucose monitoring for more than 3 months, patients able to evaluate the IPRA advices by connecting to IPRA© application 30 times a week, patient able to provide written informed consent, patient able to provide written nondisclosure agreement pregnancy or breastfeeding, current infectious disease, patients with no smartphone® or Internet access, adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Real time continuous glucose monitoring, decision support software, smartphone application.</keyword>
</DOC>